> Products > Lorlatinib API

China Lorlatinib API Factory

Being supported by an highly developed and specialist IT team, we could give technical support on pre-sales & after-sales service for Lorlatinib API,CAS NO:1454846-35-5,Lorlatinib（PF0643922） API,Lorlatinib（PF0643922）,Lorlatinib, Let's cooperate hand in hand to jointly make a beautiful upcoming. We sincerely welcome you to pay a visit to our company or speak to us for cooperation!
Lorlatinib API, Abiding by our motto of "Hold well the quality and services, Customers Satisfaction", So we provide our clients with high quality products and excellent service. Please feel free to contact us for further information.

Hot Products

17α-Hydroxyprogesterone
Product Name:17α-Hydroxyprogesterone
Molecular Formula:C21H30O3
Molecular Weight:330.46
CAS Registry Number:68-96-2
Borane-trimethylamine complex
Product Name:Borane-trimethylamine complex
Molecular Formula:C3H12BN
Molecular Weight:72.95
CAS Registry Number:75-22-9
H-ALA-ALA-OME HCL
Product Name:H-ALA-ALA-OME HCL
Molecular Formula:C7H15ClN2O3
Molecular Weight:210.66
CAS Registry Number:41036-19-5
Aprepitant
Product Name:Aprepitant
Molecular Formula:C23H21F7N4O3
Molecular Weight;534.43
CAS Registry Number;170729-80-3
(alphaS)-alpha-[[2-(4-Morpholinyl)acetyl]amino]benzenebutanoyl-L-leucyl-L-phenylalanine methyl ester
Product Name:(alphaS)-alpha-[[2-(4-Morpholinyl)acetyl]amino]benzenebutanoyl-L-leucyl-L-phenylalanine methyl ester
Molecular Formula:C32H44N4O6
Molecular Weight:580.73
CAS Registry Number:1140908-89-9
5-Bromo-2-methoxypyridine
Product Name:5-Bromo-2-methoxypyridine
Molecular Formula:C6H6BrNO
Molecular Weight:188.02
CAS Registry Number:13472-85-0

Related Blog
Reviews

What Is Ursodeoxycholic Acid Used For?
Ursodeoxycholic acid is a cholelithiant commonly used in the gastroenterology department, and also a cholelithiasis dissolving agent, so it can be used in the treatment of gallstones under normal circumstances, on the premise...
Pharmaceutical Intermediates Manufacturers - Something You Need to Know About Pharma Intermediates Industry
Pharmaceutical intermediates are actually chemical raw materials or chemical products that need to be used in the synthesis of drugs. Such chemical products...
What is an Active Pharmaceutical Ingredient (API in Pharma)?
Sandoo Pharmaceutical is a professional active pharmaceutical intermediate manufacturer, producing high quality APIs. Sandoo Pharmaceutical provides a wide range of active pharmaceutical intermediates.
How is a drug produced?
There are so many different drugs ,with different color /shape ( like capsule ,tablet or Infusion) and price . Here we would like to explain , what makes it so different? How is a drug produced?
Everything You Need To Know About Active Pharmaceutical Ingredients (API In Pharma)
Sandoo, as a professional API manufactruer in China, we produces a wide range of active pharmaceutical ingredients which can be used in the production of medicines in different applications.
FDA approves lorlatinib for second- or third-line treatment of ALK-positive metastatic NSCLC
On November 2, 2018, the Food and Drug Administration granted accelerated approval to lorlatinib (LORBRENA, Pfizer, Inc.) for patients with anaplastic lymphoma kinase (ALK)-positive metastatic non-small cell lung cancer (NSCLC) whose disease has progressed on crizotinib and at least one other ALK inhibitor for metastatic disease or whose disease has progressed on alectinib or ceritinib as the first ALK inhibitor therapy for metastatic disease.

China Lorlatinib API Factory

Related Products

Hot Products

17α-Hydroxyprogesterone

Borane-trimethylamine complex

H-ALA-ALA-OME HCL

Aprepitant

(alphaS)-alpha-[[2-(4-Morpholinyl)acetyl]amino]benzenebutanoyl-L-leucyl-L-phenylalanine methyl ester

5-Bromo-2-methoxypyridine

What Is Ursodeoxycholic Acid Used For?

Pharmaceutical Intermediates Manufacturers - Something You Need to Know About Pharma Intermediates Industry

What is an Active Pharmaceutical Ingredient (API in Pharma)?

How is a drug produced?

Everything You Need To Know About Active Pharmaceutical Ingredients (API In Pharma)

FDA approves lorlatinib for second- or third-line treatment of ALK-positive metastatic NSCLC

Meredith 2024-04-06 13:39:53

ROGER Rivkin 2023-03-18 06:48:52

Flora 2023-10-07 07:16:08

Alexandra 2023-12-06 20:26:27

Arthur 2023-04-03 18:45:02

Megan 2023-09-20 01:12:14

Send Inquiry